AMGN vs CGEM · P/E 24, rev $36.75B vs $830.3M cap
Amgen Inc (AMGN) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the AMGN and CGEM stock pages for the full models.
Not investment advice.